A comprehensive study of the downstream targets of the CAMKII pathway, such as the fetal gene program, electrical remodelling and metabolic remodelling, and the effects of targeted inhibition of the CAMKII pathway in uremia would be worthwhile. The gene discussed is CAMK2G; the disease is uremia.